A dengue outbreak among camp participants in a Caribbean Island, 1995

Journal of Travel Medicine

Volumn 7, Issue 2, 2000, Pages 59-63

  Lyerla, Rob ^a   Rigau Pérez, José G ^b,f   Vorndam, A Vance ^b   Reiter, Paul ^b   George, Aubrey M ^c   Potter, Irad M ^d   Gubler, Duane J ^e  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

^c Environmental Health Division   (Virgin Islands (British))

^d US Dept of Hlth and Hum Serv ^*  (Virgin Islands (British))

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f CDC Dengue Branch   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CARIBBEAN ISLANDS; CHILD; CLINICAL ARTICLE; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; FEVER; HUMAN; MALE; MOSQUITO; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0343183208     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00022     Document Type: Article

References (17)

1. World Health Organization. Dengue haemorrhagic fever -diagnosis, treatment, prevention and control, 2nd Ed. Geneva: World Health Organization, 1997.
2. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993; 92:111-115.
3. Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352:971-977.
4. Rigau-Pérez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue: a literature review and case study of travelers from the United States, 1986-1994. J Travel Med 1996; 4:65-71.
5. Burke DS, Nisalak A, Ussery MA. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 1982; 15:1034-1042.
6. Rosen L, Gubler DJ. The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg 1974; 23: 1153-1160.
7. Gubler DJ, Kuno G, Sather GE, Vélez M, Oliver A. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984; 33: 158-165.
8. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-551.
9. Chungue E, Marché G, Plichart R, Boutin JP, Roux J. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and hemagglutination inhibition (HI) test for the detection of dengue antibodies: prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 1989; 83:708-711.
10. Russel PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967; 99:291-296.
11. Pan American Health Organization. Guidelines for the prevention and control of dengue and dengue hemorrhagic fever in the Americas. Washington, DC: Pan American Health Organization, 1994: 12.
12. Centers for Disease Control and Prevention. Case definitions for public health surveillance. MMWR 1997; 46(No. RR-10):10-11.
13. Burke DS, Nisalak A, Johnson DE, et al. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-180.
14. Halstead SB, Udomsakdi S, Singharah P, Nisalak A. Dengue and chikungunya virus infection in man in Thailand, 1962-64. III: Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg 1969; 18:984-996.
15. Karp BE. Dengue fever: a risk to travelers. Maryland Med J 1997; 46:200-302.
16. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998; 128:931-940.
17. Gill J. An active laboratory-based surveillance program for recent dengue infections in Florida, USA: 1997 results. Am J Trop Med Hyg 1998; 59(Suppl):290.